Journal Article

Thiabendazole for the Treatment of Strongyloidiasis in Patients with Hematologic Malignancies

Rony Schaffel, Marcio Nucci, Rodrigo Portugal, Marcia B. Castro, Selma B. Ferreira, Leandro Almeida, Nelson Spector and Wolmar Pulcheri

in Clinical Infectious Diseases

Published on behalf of Infectious Diseases Society of America

Volume 31, issue 3, pages 821-822
Published in print September 2000 | ISSN: 1058-4838
Published online September 2000 | e-ISSN: 1537-6591 | DOI: https://dx.doi.org/10.1086/314023
Thiabendazole for the Treatment of Strongyloidiasis in Patients with Hematologic Malignancies

More Like This

Show all results sharing these subjects:

  • Infectious Diseases
  • Immunology
  • Public Health and Epidemiology
  • Microbiology

GO

Show Summary Details

Preview

A total of 21 patients with hematologic malignancies were given thiabendazole for treatment of strongyloidiasis. Fifteen patients were cured. Since there were no relapses, it is unlikely that maintenance therapy has a role in the management of strongyloidiasis in this population of patients.

Journal Article.  1009 words. 

Subjects: Infectious Diseases ; Immunology ; Public Health and Epidemiology ; Microbiology

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.